The Hal Lewis Group by ProQuest

VIEWS: 20 PAGES: 1

It was a "consistent" year for The Hal Lewis Group in terms of revenue and headcount, which remained at 62. The agency launched several important and successful campaigns, won new assignments from existing clients and picked up new business. AOR assignments came in from both Meda Pharmaceuticals and Azur Pharma, and project work for Organogenesis expanded to an AOR relationship. Winigrad and Maureen Mangiavas, senior director, business development, count the launch of CSL Biotherapies' flu vaccine, Afluria, among last year's greatest achievements. Winigrad is particularly pleased with the innovative nature of the launch. Regulatory limitations and cutbacks are the biggest challenges the agency faced.

More Info
To top